New research reveals significant prevalence of valvular heart disease among older Americans
Meeting Announcement
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 27-Oct-2025 21:11 ET (28-Oct-2025 01:11 GMT/UTC)
People who walk at least 10-15 minutes in a single stretch reduce their risk of developing cardiovascular disease by two thirds compared to those who walk less than five minutes in one go
When walking the same number of steps, longer accumulations of steps in one go have a greater health benefit than short bouts spread out across the day
After several years of close collaboration and a relationship rooted in mutual respect and shared vision, Fogarty Innovation is coming together with the Cardiovascular Research Foundation® (CRF®) to create a unified platform for advancing transformative healthcare technologies. This strategic combination strengthens CRF’s leadership in medtech by integrating Fogarty’s renowned expertise in early-stage innovation, creating a powerful, cross-specialty platform to accelerate transformative breakthroughs into patient care. The merger was announced during a special keynote session at the Transcatheter Cardiovascular Therapeutics® (TCT®) meeting.
Ischemic heart disease is the leading cause of death globally, causing approximately 9 million deaths annually. Currently, reperfusion therapy (such as thrombolysis or interventional procedures) is the primary method to restore myocardial blood flow. However, the ensuing myocardial ischemia-reperfusion injury (MIRI) has become a key challenge limiting therapeutic efficacy. MIRI involves multiple pathological mechanisms including inflammatory burst, oxidative stress, calcium overload, and ferroptosis. Traditional drugs struggle to effectively intervene due to poor targeting and low bioavailability. In recent years, nanomaterials have emerged as a promising strategy to address this challenge due to their unique size effects, functionable surfaces, and good biocompatibility. This article delves into the latest advances in nanomaterial-based intervention strategies for MIRI from three core dimensions.